Stephens Investment Management Group LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1314440
LITTLE ROCK, AR
Position in LGND
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$150,335,248
+$51,574,383 QoQ
Shares Held
475,609
-3.9% QoQ
Ownership
2.39%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
#13
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Stephens Investment Management Group LLC holds $693,575,126 across 7 Biotechnology names. LGND ranks #1 (21.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
475,609 | $150,335,248 | |
| 2 | EXEL |
Exelixis, Inc.
|
2,710,011 | $147,451,698 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,392,819 | $109,015,943 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
1,875,304 | $106,536,020 | |
| 5 | TWST |
Twist Bioscience Corp
|
767,364 | $78,946,408 | |
| 6 | TECH |
BIO-TECHNE Corp
|
944,697 | $66,742,843 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
281,832 | $34,546,966 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $150,335,248 | 475,609 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $98,760,865 | 494,670 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $94,731,632 | 501,040 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $98,231,569 | 554,542 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $68,755,141 | 604,813 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $63,843,321 | 607,222 | Shares | Defined | 2025-05-01 | |
| 2024-12-31 | $65,659,591 | 612,782 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $61,925,282 | 618,696 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $54,937,520 | 652,000 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $50,933,009 | 696,758 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $47,096,776 | 659,434 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $28,016,434 | 467,564 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $33,628,161 | 466,410 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $33,476,346 | 455,089 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $30,354,988 | 454,416 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $38,899,138 | 451,738 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $40,467,842 | 453,574 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $46,983,716 | 417,670 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $63,538,490 | 411,359 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $57,144,022 | 410,164 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $47,673,527 | 363,393 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $56,529,965 | 370,810 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $57,909,114 | 582,294 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $56,678,410 | 594,612 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $69,784,871 | 623,915 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $42,150,292 | 579,625 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||